LTPASXLTR Pharma Ltd

LTP price activity

Last Price

Change (24hr)

AUD (%)

Volume

Volume (4w avg)

Previous Close

N/A

Last Trade

LTP price performance

-2.15%

-20.87%

-36.81%

YTD

31.88%

LTP price fundamentals

N/A

Shares Issued

N/A

Earnings Per Share (EPS)

N/A

Dividends Per Share (DPS)

N/A

P/E Ratio

Price market cap

Market cap

N/A

AU-ASX rank

N/A

Sector Rank

N/A

LTP details

View company website

View AU-ASX Official Page

LTP Market Signals

More ways to discover

Browse Australia news Discover ASX signals Browse all ASX stocks

LTR Pharma Ltd (AU-ASX: LTP)

LTR Pharma Limited, a clinical-stage pharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia. Its lead product candidate is SPONTAN, an intranasal delivery technology, an oral PDE5 inhibitor and vardenafil HCL for the treatment of ED. The company was incorporated in 2020 and is headquartered in Brisbane, Australia.

Price: A$0.46

Sector: Healthcare — Biotechnology